Outlook Therapeutics
OTLK
OTLK
87 hedge funds and large institutions have $51.1M invested in Outlook Therapeutics in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
31
Reduced
20
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$16M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$4.79M |
| 3 |
3
Squarepoint
New York
|
$551K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$4.73M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$10.7M |
